MRI in Diagnosing and Monitoring CIDP

NCT02017769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2016-10-26

No results posted yet for this study

Summary

We want to study whether MRI can be useful in diagnosing and monitoring patients with CIDP in maintenance treatment with immunoglobulin

Conditions

  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Henning Andersen, Prof, DMSc

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02017769 on ClinicalTrials.gov